RE
SRNE

RBC Europe’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

RBC Europe’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-580
Closed -$4.42K – 1234
2021
Q3 		$4.42K Hold
580
– – ﹤0.01% 1057
2021
Q2 		$5.62K Hold
580
– – ﹤0.01% 1039
2021
Q1 		$4.8K Hold
580
– – ﹤0.01% 1003
2020
Q4 		$3.96K Hold
580
– – ﹤0.01% 998
2020
Q3 		$6.47K Hold
580
– – ﹤0.01% 873
2020
Q2 		$3.64K Buy
+580
New +$2.22K ﹤0.01% 900

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return